Avasimibe is a potent, orally bioavailable inhibitor of acyl-coenzyme A: cholesterol acyltransferase (ACAT), functioning primarily by blocking intracellular cholesterol esterification. While originally… Read more
Avasimibe is a potent, orally bioavailable inhibitor of acyl-coenzyme A: cholesterol acyltransferase (ACAT), functioning primarily by blocking intracellular cholesterol esterification. While originally investigated in clinical trials for the treatment of atherosclerosis and hypercholesterolemia, it is now primarily utilized in biomedical research as a chemical tool to study cholesterol metabolism, immune regulation, and potential antitumor mechanisms. Laboratories supporting these research areas require high-quality analytical compounds for rigorous scientific inquiry. This category includes essential reference standards, such as avasimibe sodium salt and stable isotope labelled variants like avasimibe-13C6, which are critical for accurate analytical testing. These compounds are used by pharmaceutical and research laboratories for impurity profiling, method validation, and precise quantitative analysis in quality control workflows, ensuring that experimental results remain reliable and reproducible across diverse metabolic and oncological studies.